10-K Filing

VAREX IMAGING CORP CIK: 1681622 FY 2019

Filing Information

Form Type	10-K
Accession Number	`0001681622-19-000083`
Period End Date	20190930
Filing Date	20191220
Fiscal Year	2019
Fiscal Period	FY
XBRL Instance	varex10k2019_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 81 Income Statement 63 Cash Flow Statement 131 Stockholders Equity 42 Comprehensive Income 21

Balance Sheet 81 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$600.00K	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.00M	USD	Point-in-time
Preferred stock, par value per share (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value per share (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$83.30M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$51.90M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $1.0 and $0.6 at September 27, 2019 and September 28, 2018, respectively	`AccountsReceivableNetCurrent`	$154.00M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $1.0 and $0.6 at September 27, 2019 and September 28, 2018, respectively	`AccountsReceivableNetCurrent`	$141.00M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$248.20M	USD	Point-in-time
Common stock, par value per share (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value per share (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$235.10M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$23.50M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$19.30M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$438.40M	USD	Point-in-time
Common stock, shares, issued (in shares)	`CommonStockSharesIssued`	38.03M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$458.10M	USD	Point-in-time
Common stock, shares, issued (in shares)	`CommonStockSharesIssued`	38.37M	shares	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$144.90M	USD	Point-in-time
Common stock, shares, outstanding (in shares)	`CommonStockSharesOutstanding`	38.03M	shares	Point-in-time
Common stock, shares, outstanding (in shares)	`CommonStockSharesOutstanding`	38.37M	shares	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$142.30M	USD	Point-in-time
Goodwill	`Goodwill`	$243.60M	USD	Point-in-time
Goodwill	`Goodwill`	$290.80M	USD	Point-in-time
Intangibles assets, net	`IntangibleAssetsNetExcludingGoodwill`	$86.30M	USD	Point-in-time
Intangibles assets, net	`IntangibleAssetsNetExcludingGoodwill`	$73.80M	USD	Point-in-time
Investments in privately-held companies	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$53.60M	USD	Point-in-time
Investments in privately-held companies	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$51.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$34.50M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$27.50M	USD	Point-in-time
Total assets	`Assets`	$1.04B	USD	Point-in-time
Total assets	`Assets`	$987.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$66.30M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$58.20M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$75.70M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$54.60M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtCurrent`	$25.00M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtCurrent`	$30.70M	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$10.50M	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$13.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$175.10M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$152.00M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$364.80M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$364.40M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$22.40M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$8.20M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$29.80M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$32.50M	USD	Point-in-time
Total liabilities	`Liabilities`	$580.20M	USD	Point-in-time
Total liabilities	`Liabilities`	$548.50M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$10.50M	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$11.10M	USD	Point-in-time
Preferred stock, $.01 par value: 20,000,000 shares authorized, none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.01 par value: 20,000,000 shares authorized, none issued	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.01 par value: 150,000,000 shares authorized, shares issued and outstanding: 38,371,305 and 38,026,597 at September 27, 2019 and September 28, 2018, respectively	`CommonStockValue`	$400.00K	USD	Point-in-time
Common stock, $.01 par value: 150,000,000 shares authorized, shares issued and outstanding: 38,371,305 and 38,026,597 at September 27, 2019 and September 28, 2018, respectively	`CommonStockValue`	$400.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$357.60M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$371.80M	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$5.80M	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.70M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$58.90M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$74.40M	USD	Point-in-time
Total Varex stockholders' equity	`StockholdersEquity`	$444.90M	USD	Point-in-time
Total Varex stockholders' equity	`StockholdersEquity`	$426.20M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$3.30M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$2.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$379.00M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$428.30M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$448.20M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$526.00M	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$1.04B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$987.90M	USD	Point-in-time

Income Statement 63 line items

Line Item	Tag	Value	Unit	Period
Revenues, net	`Revenues`	$780.60M	USD	Annual
Revenues, net	`Revenues`	$698.10M	USD	Annual
Revenues, net	`Revenues`	$773.40M	USD	Annual
Cost of revenues	`CostOfRevenue`	$519.50M	USD	Annual
Cost of revenues	`CostOfRevenue`	$523.90M	USD	Annual
Cost of revenues	`CostOfRevenue`	$444.60M	USD	Annual
Gross margin	`GrossProfit`	$253.50M	USD	Annual
Gross margin	`GrossProfit`	$253.90M	USD	Annual
Gross margin	`GrossProfit`	$256.70M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$67.30M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$83.00M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$78.10M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$128.10M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$102.50M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$123.40M	USD	Annual
Impairment of intangible assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$4.80M	USD	Annual
Impairment of intangible assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Impairment of intangible assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$3.00M	USD	Annual
Total operating expenses	`OperatingExpenses`	$211.00M	USD	Annual
Total operating expenses	`OperatingExpenses`	$209.40M	USD	Annual
Total operating expenses	`OperatingExpenses`	$169.80M	USD	Annual
Operating earnings	`OperatingIncomeLoss`	$83.70M	USD	Annual
Operating earnings	`OperatingIncomeLoss`	$44.50M	USD	Annual
Operating earnings	`OperatingIncomeLoss`	$45.70M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$200.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$100.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$200.00K	USD	Annual
Interest expense	`InterestExpense`	$21.70M	USD	Annual
Interest expense	`InterestExpense`	$21.10M	USD	Annual
Interest expense	`InterestExpense`	$12.30M	USD	Annual
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-3.20M	USD	Annual
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$3.20M	USD	Annual
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$2.70M	USD	Annual
Interest and other expenses, net	`NonoperatingIncomeExpense`	$-24.20M	USD	Annual
Interest and other expenses, net	`NonoperatingIncomeExpense`	$-18.80M	USD	Annual
Interest and other expenses, net	`NonoperatingIncomeExpense`	$-8.90M	USD	Annual
Earnings before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$25.70M	USD	Annual
Earnings before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$21.50M	USD	Annual
Earnings before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$74.80M	USD	Annual
Taxes (benefit) on earnings	`IncomeTaxExpenseBenefit`	$-2.60M	USD	Annual
Taxes (benefit) on earnings	`IncomeTaxExpenseBenefit`	$5.70M	USD	Annual
Taxes (benefit) on earnings	`IncomeTaxExpenseBenefit`	$22.80M	USD	Annual
Net earnings	`ProfitLoss`	$28.30M	USD	Annual
Net earnings	`ProfitLoss`	$15.80M	USD	Annual
Net earnings	`ProfitLoss`	$52.00M	USD	Annual
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$300.00K	USD	Annual
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$800.00K	USD	Annual
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$400.00K	USD	Annual
Net earnings attributable to Varex	`NetIncomeLoss`	$51.60M	USD	Annual
Net earnings attributable to Varex	`NetIncomeLoss`	$27.50M	USD	Annual
Net earnings attributable to Varex	`NetIncomeLoss`	$15.50M	USD	Annual
Basic (in USD per share)	`EarningsPerShareBasic`	$1.37	USD	Annual
Basic (in USD per share)	`EarningsPerShareBasic`	$0.73	USD	Annual
Basic (in USD per share)	`EarningsPerShareBasic`	$0.41	USD	Annual
Diluted (in USD per share)	`EarningsPerShareDiluted`	$0.72	USD	Annual
Diluted (in USD per share)	`EarningsPerShareDiluted`	$0.40	USD	Annual
Diluted (in USD per share)	`EarningsPerShareDiluted`	$1.36	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.20M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	37.90M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	37.60M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.00M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.60M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.40M	shares	Annual

Cash Flow Statement 131 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$28.30M	USD	Annual
Net earnings	`ProfitLoss`	$15.80M	USD	Annual
Net earnings	`ProfitLoss`	$52.00M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$10.00M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$8.40M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$11.70M	USD	Annual
Depreciation	`Depreciation`	$23.50M	USD	Annual
Depreciation	`Depreciation`	$16.90M	USD	Annual
Depreciation	`Depreciation`	$26.00M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$16.20M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$15.70M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$10.50M	USD	Annual
Impairment of intangible assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Impairment of intangible assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$3.00M	USD	Annual
Impairment of intangible assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$4.80M	USD	Annual
Other assets impairment charges	`OtherAssetImpairmentCharges`	$1.30M	USD	Annual
Other assets impairment charges	`OtherAssetImpairmentCharges`	-	USD	Annual
Other assets impairment charges	`OtherAssetImpairmentCharges`	-	USD	Annual
Inventory write-down	`InventoryWriteDown`	$3.10M	USD	Annual
Inventory write-down	`InventoryWriteDown`	-	USD	Annual
Inventory write-down	`InventoryWriteDown`	$3.10M	USD	Annual
Deferred taxes	`DeferredIncomeTaxExpenseBenefitExcludingPortiontoAPIC`	$-7.70M	USD	Annual
Deferred taxes	`DeferredIncomeTaxExpenseBenefitExcludingPortiontoAPIC`	$-8.90M	USD	Annual
Deferred taxes	`DeferredIncomeTaxExpenseBenefitExcludingPortiontoAPIC`	$-12.90M	USD	Annual
Amortization of deferred loan costs	`AmortizationOfFinancingCosts`	$1.80M	USD	Annual
Amortization of deferred loan costs	`AmortizationOfFinancingCosts`	$2.30M	USD	Annual
Amortization of deferred loan costs	`AmortizationOfFinancingCosts`	$2.40M	USD	Annual
Loss (gain) from equity method investments, net of dividends received	`IncomeLossFromEquityMethodInvestments`	$-2.30M	USD	Annual
Loss (gain) from equity method investments, net of dividends received	`IncomeLossFromEquityMethodInvestments`	$3.90M	USD	Annual
Loss (gain) from equity method investments, net of dividends received	`IncomeLossFromEquityMethodInvestments`	$1.30M	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$-1.80M	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$-800.00K	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$-700.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-14.80M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$23.10M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-9.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$4.20M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$11.10M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$2.40M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-2.00M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-4.30M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$10.10M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-9.00M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.90M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$5.20M	USD	Annual
Accrued operating liabilities and other long-term operating liabilities	`IncreaseDecreaseInAccruedLiabilities`	$10.90M	USD	Annual
Accrued operating liabilities and other long-term operating liabilities	`IncreaseDecreaseInAccruedLiabilities`	$28.10M	USD	Annual
Accrued operating liabilities and other long-term operating liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-10.20M	USD	Annual
Deferred revenues	`IncreaseDecreaseInDeferredRevenue`	$-1.60M	USD	Annual
Deferred revenues	`IncreaseDecreaseInDeferredRevenue`	$2.40M	USD	Annual
Deferred revenues	`IncreaseDecreaseInDeferredRevenue`	$-5.20M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$85.30M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$71.90M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$75.20M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.20M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.40M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.80M	USD	Annual
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$271.80M	USD	Annual
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$4.80M	USD	Annual
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$69.50M	USD	Annual
Investments in privately-held companies	`PaymentsToAcquireEquityMethodInvestments`	$3.90M	USD	Annual
Investments in privately-held companies	`PaymentsToAcquireEquityMethodInvestments`	-	USD	Annual
Investments in privately-held companies	`PaymentsToAcquireEquityMethodInvestments`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-25.20M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-292.00M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-93.20M	USD	Annual
Net transfers from parent	`ProceedsFromContributionsFromParent`	-	USD	Annual
Net transfers from parent	`ProceedsFromContributionsFromParent`	$5.00M	USD	Annual
Net transfers from parent	`ProceedsFromContributionsFromParent`	-	USD	Annual
Distributions to Varian Medical Systems, Inc.	`PaymentsOfDistributionsToAffiliates`	$227.10M	USD	Annual
Distributions to Varian Medical Systems, Inc.	`PaymentsOfDistributionsToAffiliates`	-	USD	Annual
Distributions to Varian Medical Systems, Inc.	`PaymentsOfDistributionsToAffiliates`	-	USD	Annual
Taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.90M	USD	Annual
Taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$2.30M	USD	Annual
Taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$2.10M	USD	Annual
Borrowings under credit agreements	`ProceedsFromLongTermLinesOfCredit`	$10.00M	USD	Annual
Borrowings under credit agreements	`ProceedsFromLongTermLinesOfCredit`	$749.00M	USD	Annual
Borrowings under credit agreements	`ProceedsFromLongTermLinesOfCredit`	$85.40M	USD	Annual
Repayments of borrowing under credit agreements	`RepaymentsOfLongTermLinesOfCredit`	$255.00M	USD	Annual
Repayments of borrowing under credit agreements	`RepaymentsOfLongTermLinesOfCredit`	$87.00M	USD	Annual
Repayments of borrowing under credit agreements	`RepaymentsOfLongTermLinesOfCredit`	$106.00M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$2.80M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$800.00K	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$3.80M	USD	Annual
Proceeds from shares issued under employee stock purchase plan	`ProceedsFromStockPlans`	$3.80M	USD	Annual
Proceeds from shares issued under employee stock purchase plan	`ProceedsFromStockPlans`	-	USD	Annual
Proceeds from shares issued under employee stock purchase plan	`ProceedsFromStockPlans`	$3.30M	USD	Annual
Excess tax benefits from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	-	USD	Annual
Excess tax benefits from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$2.40M	USD	Annual
Excess tax benefits from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	-	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$400.00K	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$500.00K	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$11.90M	USD	Annual
Contributions from noncontrolling partner	`ProceedsFromMinorityShareholders`	-	USD	Annual
Contributions from noncontrolling partner	`ProceedsFromMinorityShareholders`	$1.80M	USD	Annual
Contributions from noncontrolling partner	`ProceedsFromMinorityShareholders`	-	USD	Annual
Dividends paid to redeemable noncontrolling interest	`PaymentsOfDividendsMinorityInterest`	$600.00K	USD	Annual
Dividends paid to redeemable noncontrolling interest	`PaymentsOfDividendsMinorityInterest`	-	USD	Annual
Dividends paid to redeemable noncontrolling interest	`PaymentsOfDividendsMinorityInterest`	$500.00K	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-90.40M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$263.30M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-100.00K	USD	Annual
Effects of exchange rate changes on cash and cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-700.00K	USD	Annual
Effects of exchange rate changes on cash and cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-500.00K	USD	Annual
Effects of exchange rate changes on cash and cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$900.00K	USD	Annual
Net (decrease) increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-30.80M	USD	Annual
Net (decrease) increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$47.40M	USD	Annual
Net (decrease) increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-22.10M	USD	Annual
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.20M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$31.30M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$36.80M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$53.40M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$53.40M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$36.80M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$31.30M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.20M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$19.90M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$19.30M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$9.80M	USD	Annual
Cash paid for income tax	`IncomeTaxesPaid`	$8.20M	USD	Annual
Cash paid for income tax	`IncomeTaxesPaid`	$6.00M	USD	Annual
Cash paid for income tax	`IncomeTaxesPaid`	$13.80M	USD	Annual
Purchases of property, plant and equipment financed through accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$4.00M	USD	Annual
Purchases of property, plant and equipment financed through accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$2.00M	USD	Annual
Purchases of property, plant and equipment financed through accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$1.80M	USD	Annual
Transfers of property, plant and equipment from Varian Medical Systems, Inc.	`ReceiptofProperty`	$15.00M	USD	Annual
Transfers of property, plant and equipment from Varian Medical Systems, Inc.	`ReceiptofProperty`	-	USD	Annual
Transfers of property, plant and equipment from Varian Medical Systems, Inc.	`ReceiptofProperty`	-	USD	Annual
Other non-cash transfers to Varian Medical Systems, Inc.	`NoncashTransferstoParent`	-	USD	Annual
Other non-cash transfers to Varian Medical Systems, Inc.	`NoncashTransferstoParent`	-	USD	Annual
Other non-cash transfers to Varian Medical Systems, Inc.	`NoncashTransferstoParent`	$1.60M	USD	Annual

Stockholders Equity 42 line items

Line Item	Tag	Value	Unit	Period
Shares outstanding, beginning of period (in shares)	`CommonStockSharesOutstanding`	38.37M	shares	Point-in-time
Shares outstanding, beginning of period (in shares)	`CommonStockSharesOutstanding`	38.03M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$379.00M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$428.30M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$448.20M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$526.00M	USD	Point-in-time
Effect of adoption of ASC 606	`CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption`	$-3.50M	USD	Point-in-time
Net earnings	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$15.30M	USD	Annual
Net earnings	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$51.60M	USD	Annual
Net earnings	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$27.80M	USD	Annual
Net transfers to parent	`NetTransfersFromToParent`	$18.40M	USD	Annual
Other	`StockholdersEquityOther`	$200.00K	USD	Annual
Other	`StockholdersEquityOther`	$200.00K	USD	Annual
Distribution to Varian Medical Systems	`DistributionstoParent`	$227.10M	USD	Annual
Conversion of net parent investment into common stock	`StockIssuedDuringPeriodValueConversionOfUnits`	-	USD	Annual
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	35,000.00	shares	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.80M	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.80M	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$800.00K	USD	Annual
Shares withheld on vesting of restricted stock	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$2.10M	USD	Annual
Shares withheld on vesting of restricted stock	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.90M	USD	Annual
Shares withheld on vesting of restricted stock	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$2.20M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.00M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.70M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.20M	USD	Annual
Unrealized gain on interest rate swap contracts, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$5.20M	USD	Annual
Unrealized gain on interest rate swap contracts, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-6.20M	USD	Annual
Unrealized gain on interest rate swap contracts, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$600.00K	USD	Annual
Unrealized gain (loss) on defined benefit obligations	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$200.00K	USD	Annual
Unrealized gain (loss) on defined benefit obligations	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-200.00K	USD	Annual
Unrealized gain (loss) on defined benefit obligations	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$1.30M	USD	Annual
Tax impacts to APIC related to share-based award activity	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$2.40M	USD	Annual
Common stock issued under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$3.80M	USD	Annual
Common stock issued under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$3.30M	USD	Annual
Capital contribution by noncontrolling interest	`NoncontrollingInterestIncreaseFromCapitalContribution`	$1.80M	USD	Annual
Noncontrolling interest acquired/consolidated	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$1.40M	USD	Annual
Shares outstanding, end of period (in shares)	`CommonStockSharesOutstanding`	38.37M	shares	Point-in-time
Shares outstanding, end of period (in shares)	`CommonStockSharesOutstanding`	38.03M	shares	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$379.00M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$428.30M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$448.20M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$526.00M	USD	Point-in-time

Comprehensive Income 21 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$28.30M	USD	Annual
Net earnings	`ProfitLoss`	$15.80M	USD	Annual
Net earnings	`ProfitLoss`	$52.00M	USD	Annual
Unrealized (loss) gain on interest rate swap contracts	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$5.20M	USD	Annual
Unrealized (loss) gain on interest rate swap contracts	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-6.20M	USD	Annual
Unrealized (loss) gain on interest rate swap contracts	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$600.00K	USD	Annual
Unrealized (loss) gain on defined benefit obligations	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$200.00K	USD	Annual
Unrealized (loss) gain on defined benefit obligations	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-200.00K	USD	Annual
Unrealized (loss) gain on defined benefit obligations	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$1.30M	USD	Annual
Other comprehensive (loss) earnings, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$800.00K	USD	Annual
Other comprehensive (loss) earnings, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$5.00M	USD	Annual
Other comprehensive (loss) earnings, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-7.50M	USD	Annual
Comprehensive earnings	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$52.80M	USD	Annual
Comprehensive earnings	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$8.30M	USD	Annual
Comprehensive earnings	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$33.30M	USD	Annual
Less: Comprehensive earnings attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$400.00K	USD	Annual
Less: Comprehensive earnings attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$800.00K	USD	Annual
Less: Comprehensive earnings attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$300.00K	USD	Annual
Comprehensive earnings attributable to Varex	`ComprehensiveIncomeNetOfTax`	$32.50M	USD	Annual
Comprehensive earnings attributable to Varex	`ComprehensiveIncomeNetOfTax`	$8.00M	USD	Annual
Comprehensive earnings attributable to Varex	`ComprehensiveIncomeNetOfTax`	$52.40M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.